


















UCLA partners with Autobahn Labs 'virtual incubator' with drug maker and VC based on new model
According to reporting by Ron Leuty of San Francisco Business Times UCLA has joined into a partnership with German drug maker Evotec SE, Palo Alto Samsara BioCapital, and family fund KCK Ltd. to launch the Autobahn Labs virtual incubator. The novel incubator is based on the concept of a bridge model to fast-track early-stage academic research into startup companies.
